Literature DB >> 31935289

Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma.

Tim M Illidge1,2, Elizabeth H Phillips3, Nicholas Counsell3, Ruth Pettengell4, Peter W M Johnson5, Dominic J Culligan6, Bilyana Popova3, Laura Clifton-Hadley3, Andrew McMillan7, Peter Hoskin1,2,8, Sally F Barrington9, John Radford1,2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31935289      PMCID： PMC6960465          DOI： 10.1182/bloodadvances.2019001023

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  10 in total

1.  Definition of bulky disease in early stage Hodgkin lymphoma in computed tomography era: prognostic significance of measurements in the coronal and transverse planes.

Authors:  Anita Kumar; Irene A Burger; Zhigang Zhang; Esther N Drill; Jocelyn C Migliacci; Andrea Ng; Ann LaCasce; Darci Wall; Thomas E Witzig; Kay Ristow; Joachim Yahalom; Craig H Moskowitz; Andrew D Zelenetz
Journal:  Haematologica       Date:  2016-07-06       Impact factor: 9.941

2.  Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.

Authors:  T A Lister; D Crowther; S B Sutcliffe; E Glatstein; G P Canellos; R C Young; S A Rosenberg; C A Coltman; M Tubiana
Journal:  J Clin Oncol       Date:  1989-11       Impact factor: 44.544

3.  How do we move towards a personalised approach in the treatment of Early Hodgkin lymphoma?

Authors:  Maja V Maraldo; Tim M Illidge
Journal:  Br J Haematol       Date:  2018-05-22       Impact factor: 6.998

4.  Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study.

Authors:  Sally F Barrington; Elizabeth H Phillips; Nicholas Counsell; Barry Hancock; Ruth Pettengell; Peter Johnson; William Townsend; Dominic Culligan; Bilyana Popova; Laura Clifton-Hadley; Andrew McMillan; Peter Hoskin; Michael J O'Doherty; Tim Illidge; John Radford
Journal:  J Clin Oncol       Date:  2019-05-21       Impact factor: 44.544

5.  Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial.

Authors:  Anne-Ségolène Cottereau; Annibale Versari; Annika Loft; Olivier Casasnovas; Monica Bellei; Romain Ricci; Stéphane Bardet; Antonio Castagnoli; Pauline Brice; John Raemaekers; Bénédicte Deau; Catherine Fortpied; Tiana Raveloarivahy; Emelie Van Zele; Loic Chartier; Thierry Vander Borght; Massimo Federico; Martin Hutchings; Umberto Ricardi; Marc Andre; Michel Meignan
Journal:  Blood       Date:  2018-02-01       Impact factor: 22.113

6.  Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.

Authors:  Bruce D Cheson; Richard I Fisher; Sally F Barrington; Franco Cavalli; Lawrence H Schwartz; Emanuele Zucca; T Andrew Lister
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

7.  Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.

Authors:  Marc P E André; Théodore Girinsky; Massimo Federico; Oumédaly Reman; Catherine Fortpied; Manuel Gotti; Olivier Casasnovas; Pauline Brice; Richard van der Maazen; Alessandro Re; Véronique Edeline; Christophe Fermé; Gustaaf van Imhoff; Francesco Merli; Réda Bouabdallah; Catherine Sebban; Lena Specht; Aspasia Stamatoullas; Richard Delarue; Valeria Fiaccadori; Monica Bellei; Tiana Raveloarivahy; Annibale Versari; Martin Hutchings; Michel Meignan; John Raemaekers
Journal:  J Clin Oncol       Date:  2017-03-14       Impact factor: 44.544

8.  Impact of risk factors on outcomes in early-stage Hodgkin's lymphoma: an analysis of international staging definitions.

Authors:  B Klimm; H Goergen; M Fuchs; B von Tresckow; B Böll; J Meissner; A Glunz; V Diehl; H T Eich; A Engert; P Borchmann
Journal:  Ann Oncol       Date:  2013-10-22       Impact factor: 32.976

9.  Risk factors and a prognostic score for survival after autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma.

Authors:  P J Bröckelmann; H Müller; O Casasnovas; M Hutchings; B von Tresckow; M Jürgens; S J McCall; F Morschhauser; M Fuchs; P Borchmann; C H Moskowitz; A Engert
Journal:  Ann Oncol       Date:  2017-06-01       Impact factor: 32.976

10.  Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma.

Authors:  John Radford; Tim Illidge; Nicholas Counsell; Barry Hancock; Ruth Pettengell; Peter Johnson; Jennie Wimperis; Dominic Culligan; Bilyana Popova; Paul Smith; Andrew McMillan; Alison Brownell; Anton Kruger; Andrew Lister; Peter Hoskin; Michael O'Doherty; Sally Barrington
Journal:  N Engl J Med       Date:  2015-04-23       Impact factor: 91.245
  10 in total
  4 in total

1.  ABVD followed by BV consolidation in risk-stratified patients with limited-stage Hodgkin lymphoma.

Authors:  Steven I Park; Thomas C Shea; Oludamilola Olajide; Nishitha M Reddy; Lihua E Budde; Nilanjan Ghosh; Allison M Deal; Jeanne F Noe; Stephen M Ansell
Journal:  Blood Adv       Date:  2020-06-09

2.  Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin Lymphoma.

Authors:  David J Cutter; Johanna Ramroth; Patricia Diez; Andy Buckle; Georgios Ntentas; Bilyana Popova; Laura Clifton-Hadley; Peter J Hoskin; Sarah C Darby; John Radford; Tim Illidge
Journal:  J Clin Oncol       Date:  2021-08-13       Impact factor: 50.717

3.  Outcomes of patients with stage I-II Hodgkin lymphoma who had uniform pre-treatment staging with PET/CT and treatment with limited field radiation therapy after chemotherapy.

Authors:  Kelsey M Frechette; Scott C Lester; Kekoa Taparra; William G Breen; James A Martenson; Bradford S Hoppe; Jennifer L Peterson; William G Rule; Scott L Stafford; Bradley J Stish; Thomas M Habermann; Jason R Young; William S Harmsen; Nadia N Laack
Journal:  Blood Cancer J       Date:  2022-08-22       Impact factor: 9.812

4.  Informing radiotherapy decisions in stage I/IIa Hodgkin lymphoma: modeling life expectancy using radiation dosimetry.

Authors:  David A Jones; Paolo Candio; Rebecca Shakir; Georgios Ntentas; Johanna Ramroth; Alastair M Gray; David J Cutter
Journal:  Blood Adv       Date:  2022-02-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.